93 research outputs found
Drug Resistance in Visceral Leishmaniasis
Visceral leishmaniasis remains a public health problem worldwide. This illness was included by the World Health Organization in the list of neglected tropical diseases targeted for elimination by 2015. The widespread emergence of resistance to pentavalent antimonials in India where half cases occur globally and the unavailability of a vaccine in clinical use constitute major obstacles in achieving this goal. The last decade new antileishmanials became available, including the oral agent miltefosine. However, in poor endemic countries their wide use was curtailed because of the high costs, and also due to concerns of toxicity and emergence of resistance. Various mechanisms of antileishmanial resistance were identified recently in field isolates. Their elucidation will boost the design of new drugs and the molecular surveillance of resistance. Combination regimens should be evaluated in large trials. Overall, the development of antileishmanials has been generally slow; new drugs are needed. In order to control visceral leishmaniasis worldwide, treatment advances should become affordable in the poorest countries, where they are needed most
Adolescents Traveling to High-Risk Destinations: Review and Considerations for Clinicians
Introduction: International travels have increased dramatically in recent years. Adolescents constitute a fast-growing group of travelers. Travels provide an opportunity for exposure to high-risk behavior. The current study reviewed the published data about travel-related morbidity among adolescents traveling to international destinations. Methods: PubMed was searched for articles published from 2000-2017. The websites of public health organizations were also searched. Results: In total, 21 articles presenting original data about adolescent international travelers were identified. The data indicated that adolescents frequently develop ailments during travel, including those attributable to age-related high-risk behavior. In addition, adolescents often manifest a travel-associated morbidity that differs in terms of proportion (e.g., higher rates of systemic febrile illness) from the travel-associated morbidity encountered in younger children and adults. Pre-travel counseling is sought by less than half of adolescents traveling to high-risk destinations. Gaps were found in travel vaccinations and antimalarial prophylaxis in adolescents traveling to endemic areas. Information about vaccinations, antimalarial prophylaxis, and pre-travel counseling for adolescent travelers should be improved. Conclusion: There is a need to improve pre-travel services for adolescents planning to travel to high-risk international destinations. Communication strategies to access adolescent travelers and their parents should be investigated
Vaccination and malaria prophylaxis among Greek international travelers to Asian destinations
SummaryBackgroundInternational travel is rapidly increasing worldwide, and the greatest increases have occurred in tropical and subtropical areas. The aim of the survey was to investigate the pre-travel health-seeking practices of travelers to Asian destinations.MethodsA questionnaire-based survey was conducted at the Athens International Airport between the 1st of November 2011 and the 30th of April 2013.ResultsA total of 1666 adult travelers participated in the study, and 69.7% were men. The mean age of the participants was 39 years. Previous travel to tropical countries was reported by 69% of the participants. The most frequent destination was the Indian subcontinent (45.0%). The main reasons for travel were visiting friends and relatives (VFRs; 36.5%) and business (32.4%). Most of the participants traveled for <1 month (51.4%). Only 24.5% pursued pre-travel consultations. Vaccinations were administered to 14.4% of the participants, and of those, 77%, 73%, and 32.5% received hepatitis A, tetanus/diphtheria, and typhoid vaccines, respectively. Malaria prophylaxis was given to 12.2% of the participants. Logistic regression analysis revealed that being male and unemployed, having an elementary level of education, traveling to visiting friends and relatives, and short durations of travel were significant determinants of not seeking pre-travel consultations.ConclusionSignificant gaps were revealed in the vaccinations and malaria prophylaxes of travelers departing to Asia. Specific educational tools should be developed to improve the awareness of travelers to high-risk destinations
Editorial: Occupational risks of healthcare personnel
Healthcare personnel (HCP), and especially those working in front-line roles, are at increased risk for occupational exposure to a variety of infections, including vaccine-preventable diseases. At the same time, HCP are exposed not only to environmental risks (e.g., biological, physical, and chemical risks) but also to psychological stress, which was exceptionally intensified during the coronavirus disease 2019 (COVID-19) pandemic. As such, ensuring safety within healthcare facilities and creating health-promoting workplaces is becoming increasingly relevant in a globalizing workplace..
Impact of European vaccination policies on seasonal influenza vaccination coverage rates : An update seven years later
Publisher Copyright: © 2018, © 2018 The Author(s). Published with license by Taylor & Francis Group, LLC.Seasonal influenza can have serious morbid consequences and can even result in death, particularly in at-risk populations, including healthcare professionals (HCPs), elderly and those living with a medical risk condition. Although in Europe recommendations exist for annual influenza vaccination in these populations in most countries, the vaccination coverage rate (VCR) is often well below the World Health Organization target of 75% coverage. In our previous survey in 2009 we showed that some elements of national vaccination policies, e.g. reminder systems, strong official recommendation, and easy access, seemed to contribute to achieving higher influenza VCRs among elderly. We repeated the survey in 2016, using the same methodology to assess changes in influenza VCRs among the elderly and in the impact of policy elements on these VCRs. In addition, we collected information about VCRs among HCPs, and those living with a medical risk condition. The median VCR in the 21 countries that had recommendations for influenza vaccination in the elderly was 35.3%, ranging from 1.1% in Estonia to 74.5% in Scotland. The average VCRs for HCPs and those living with medical risk conditions, available in 17 and 10 countries, respectively, were 28.3% (range 7% in Czech Republic to 59.1% in Portugal) and 32.2% (range from 20.0% in the Czech Republic and Hungary to 59.6% in Portugal), respectively. Fewer countries were able to provide data from HCP and those living with medical risk conditions. Since the initial survey during the 2007–2008 influenza season, VCRs have decreased in the elderly in the majority of countries, thus, achieving high VCRs in the elderly and the other target groups is still a major public health challenge in Europe. This could be addressed by the identification, assessment and sharing of best practice for influenza vaccination policies.publishersversionPeer reviewe
Isolation facilities for highly infectious diseases in Europe - A cross-sectional analysis in 16 countries
BACKGROUND: Highly Infectious Diseases (HIDs) are (i) easily
transmissible form person to person; (ii) cause a
life-threatening illness with no or few treatment options; and
(iii) pose a threat for both personnel and the public. Hence,
even suspected HID cases should be managed in specialised
facilities minimizing infection risks but allowing
state-of-the-art critical care. Consensus statements on the
operational management of isolation facilities have been
published recently. The study presented was set up to compare
the operational management, resources, and technical equipment
among European isolation facilities. Due to differences in
geography, population density, and national response plans it
was hypothesized that adherence to recommendations will vary.
METHODS AND FINDINGS: Until mid of 2010 the European Network for
Highly Infectious Diseases conducted a cross-sectional analysis
of isolation facilities in Europe, recruiting 48 isolation
facilities in 16 countries. Three checklists were disseminated,
assessing 44 items and 148 specific questions. The median
feedback rate for specific questions was 97.9% (n = 47/48)
(range: n = 7/48 (14.6%) to n = 48/48 (100%). Although all
facilities enrolled were nominated specialised facilities'
serving countries or regions, their design, equipment and
personnel management varied. Eighteen facilities fulfilled the
definition of a High Level Isolation Unit'. In contrast, 24
facilities could not operate independently from their co-located
hospital, and five could not ensure access to equipment
essential for infection control. Data presented are not
representative for the EU in general, as only 16/27 (59.3%) of
all Member States agreed to participate. Another limitation of
this study is the time elapsed between data collection and
publication; e.g. in Germany one additional facility opened in
the meantime. CONCLUSION: There are disparities both within and
between European countries regarding the design and equipment of
isolation facilities. With regard to the International Health
Regulations, terminology, capacities and equipment should be
standardised
Crimean-Congo hemorrhagic fever: epidemiological trends and controversies in treatment
Crimean-Congo hemorrhagic fever (CCHF) virus has the widest geographic range of all tick-borne viruses and is endemic in more than 30 countries in Eurasia and Africa. Over the past decade, new foci have emerged or re-emerged in the Balkans and neighboring areas. Here we discuss the factors influencing CCHF incidence and focus on the main issue of the use of ribavirin for treating this infection. Given the dynamics of CCHF emergence in the past decade, development of new anti-viral drugs and a vaccine is urgently needed to treat and prevent this acute, life-threatening disease
The role of healthcare providers in HPV vaccination programs - A meeting report
The Human Papillomavirus (HPV) Prevention and Control Board convened a meeting in Bucharest, Romania (May 2018), to discuss the role of healthcare providers (HCPs) in prevention programs, with a focus on HPV vaccination and cervical cancer screening. International and local experts discussed the role that HCPs can play to increase the uptake of HPV vaccine and screening. Experts recommended: 1) increasing HCP norms of getting vaccinated; 2) training providers to make effective recommendations; 3) making culturally appropriate materials available, in local languages; and 4) centralizing and coordinating education and information material, to direct both HCPs and the general public to the best material available
Infection control management of patients with suspected highly infectious diseases in emergency departments: data from a survey in 41 facilities in 14 European countries
Heli Siikamäki on työryhmän EuroNHID Working Group jäsen.Peer reviewe
- …